NEW AGE FOR NUCLEAR MEDICINE
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.
Recent News
Launch of Rareminds Wellbeing Hub and Rare Minds Matter Survey Results
- Launch of Rareminds Wellbeing Hub and Release of "Rare Minds Matter - Rare Disease and Mental Health 2023 Survey Results" We are thrilled to announce the launch of the Rareminds Wellbeing Hub, a vital resource designed to help individuals navigate some of the more...
NICE Recommends SIRT Therapy for neuroendocrine tumours
We are delighted to share with you the news that NICE has recommended SIRT (selective internal radiation therapy) for the treatment of neuroendocrine tumour-related liver metastases. NICE Interventional procedures guidance [IPG786]: Selective internal radiation...
Shape the future of Neuroendocrine Cancer UK: Complete our survey today
At Neuroendocrine Cancer UK we want to ensure we continue to meet your needs and support you in the way you want to be supported. Please complete our survey to allow us to do this. It will take about 15 minutes. Your feedback is so important to us because it...